| Use of L-alpha-lysophasphatidylcholine (LPC) as adjuvant for vaccination
|
| |
| Technical Description : |
| By virtue of their abilities to develop an immune response and to initiate a specific T lymphocyte response, mature dendritic cells (DC) are of particular therapeutic interest, in particular in the field of anti-infectious and antitumor immunization and immunotherapy. The present invention relates to the use of L-alpha-lysophosphatidylcholine (LPC) for differentiating ex-vivo monocytes into mature DC and the use of LPS as an immunoadjuvant for the preparation of anti-invective or anti-cancer vaccines. |
| |
| Potential applications : |
| Collaboration and non exclusive licensing agreements for the development of prophylactic or therapeutic vaccines in the field of infectious diseases or cancer |
| |
| Intellectual property : |
| Patent Filed in March 2002; published under N |
| |
| |
|
|
Accueil
> Votre projet
> Innover
> Outils en ligne
> Bourse de technologies
Compétences pour innover
Version anlgaise
Enregistrer cette offre
Signaler un problème
